| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,421 | 5,061 | 4,594 | 6,018 | | Cost of Revenue | 1,260 | 1,588 | 1,612 | 1,573 | | | Gross Profit | 4,161 | 3,473 | 2,982 | 4,445 | | | Operating Expenses | | Research Development | 3,479 | 3,383 | 4,645 | 3,579 | | Selling General and Administrative | 1,889 | 1,517 | 1,553 | 1,404 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,206) | (1,428) | (3,216) | (538) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 227 | 322 | 375 | 473 | | Earnings Before Interest And Taxes | (980) | (1,105) | (2,841) | (65) | | Interest Expense | (1) | 1 | 1 | 1 | | Income Before Tax | (980) | (1,106) | (2,841) | (66) | | Income Tax Expense |
-
|
-
| (148) | (85) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (980) | (1,106) | (2,693) | 18 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (980) | (1,106) | (2,693) | 18 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($980) | ($1,106) | ($2,693) | $18 |
|
0.02% Nasdaq 
0.04 (1.03%) 
Income Statement
